Soft Tissue Sarcoma clinical trials at UCSD
1 in progress, 0 open to eligible people
A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma
Sorry, in progress, not accepting new patients
The main purpose of this study is to evaluate the efficacy of the combination of doxorubicin plus the study drug known as olaratumab versus doxorubicin plus placebo in participants with advanced or metastatic soft tissue sarcoma.
La Jolla, California and other locations